Message from Chief Executive of NSW Health

Message from the Chief Executive of NSW Sydney Health District congratulating Prof John Rasko OA & his team on the successful results of their gene therapy trial to treat severe Thalassaemia – describing this as “the best ever seen for human gene therapy for Thalassaemia”. Read the full message.

World-first breakthrough for Thalassaemia

Cure the Future are pleased to announce that Prof Rasko & his team at RPA have been part of an international trial – in which gene therapy has been used to successfully treat patients with the inherited blood disorder Thalassaemia. Of 22 patients with severe symptoms treated, 15 no longer require blood transfusions…

Car-T Therapy trials to get $2m Cancer Council funding

In Australia, around 3,300 people are diagnosed with pancreatic cancer each year. This devastating cancer carries one of the lowest survival rates. Professor Rasko and his team are trialling a potential new treatment for pancreatic cancer known as CAR T-cell immunotherapy. This type of treatment involves taking a patient’s own immune cells, growing them in a highly specialised clinical laboratory, reprogramming them to attack only cancer cells, and then returning them to the patient.